Zepbound savings card: eligibility, price and LillyDirect self-pay (2026)

The Zepbound savings card at a glance

Lilly runs more than one Zepbound savings card, and which one applies depends on your insurance and on which presentation is prescribed. Every price below is as shown on Lilly’s pages on Oct 19, 2026, and rechecked on Oct 20, 2026. Programs change; confirm on Lilly’s site before you fill.

The page code on the savings page reads CMAT-26402 09/2026, which dates the version reviewed for this page (Eli Lilly, Sep 1, 2026). The covered-plan card applies to the single-dose pen. The KwikPen has its own card. The not-covered price of $499 is for a 1-month fill only.

One pattern is worth noticing: the covered-plan annual cap of $1,300 equals 13 one-month fills at the $100 monthly maximum (13 × $100). The yearly cap is not a separate surprise. It is the monthly cap applied to the full 13 fills the card allows.

Which route fits which situation

This is a map of what Lilly lists for each situation, not a recommendation. Your plan’s formulary, prior authorization rules and deductible decide what you actually pay at the counter. Your prescriber or pharmacist can confirm which presentation is on your prescription.

Medicare GLP-1 Bridge and CVS Caremark

Two coverage routes sit outside the savings cards. Both are as shown on Lilly’s savings page on Oct 20, 2026 (Eli Lilly, Sep 1, 2026).

• Medicare GLP-1 Bridge. Lilly says eligible Medicare Part D patients with a Zepbound prescription for weight management may get Zepbound for no more than $50 a month. Eligibility is based on the Medicare GLP-1 Bridge clinical criteria, and Lilly states it is not a guarantee of coverage. LillyDirect shows the Bridge next to the KwikPen (Eli Lilly, Oct 19, 2026). The savings cards themselves still exclude Medicare.
• CVS Caremark. Lilly says coverage for Zepbound has been restored on select CVS Caremark formularies, starting at $25 a month. Coverage is not guaranteed, and the plan administrator decides actual benefits. Governmental beneficiaries are excluded from the $25 price.

Ask Lilly, your Part D plan or your pharmacy benefit manager whether either route applies to you.

To total the milligrams for a schedule and apply a price you enter, use the tirzepatide cost calculator.

LillyDirect self-pay: Zepbound KwikPen and single-dose vial prices

LillyDirect is Lilly’s own online pharmacy service. Self-pay means you pay cash rather than billing insurance. On Oct 19, 2026, LillyDirect showed identical self-pay prices for the multi-dose KwikPen and the single-dose vials (Eli Lilly, Oct 19, 2026).

What the page defines:

• A “month” is 28 days. For vials, that means 4 single-dose vials (Eli Lilly, Oct 19, 2026).
• Pen needles for the KwikPen, and needles and syringes for vials, are bought separately (Eli Lilly, Oct 19, 2026).
• Single-dose vials are sold only through LillyDirect (Eli Lilly, Oct 19, 2026).
• Lilly’s footnote says 2.5 mg is a starting dose and is not approved as a maintenance dose. The Zepbound label says the same (DailyMed, Aug 28, 2026).

The prices step with the dose because the label escalates in 2.5 mg steps. See the Zepbound dosing schedule for the label ladder and the tirzepatide titration tool to lay it out by date.

What the 45-day refill rule means

The $449 price for 7.5, 10, 12.5 and 15 mg holds only if the prescription is refilled within 45 days. If more time passes, LillyDirect lists regular prices of $499 for 7.5 mg and $699 for 10, 12.5 and 15 mg (Eli Lilly, Oct 19, 2026). That is a $50 difference at 7.5 mg and a $250 difference at 10 to 15 mg per 28-day fill.

As listed on Oct 19, 2026, the 2.5 mg and 5 mg prices carry no 45-day condition. Each fill covers 28 days, so the 45-day window leaves 17 days of slack after a fill runs out. A delayed refill, a gap in treatment or a prescription renewal that takes longer than expected can push a fill past the window.

How Zepbound self-pay prices changed: a dated history

Lilly has changed Zepbound self-pay pricing several times. These are the dated steps we could confirm from Lilly’s own releases and pages.

The Dec 1, 2025 release also listed higher regular vial prices for people outside the refill program: $599 (7.5 mg), $699 (10 mg), $849 (12.5 mg) and $1,049 (15 mg) (Eli Lilly, Dec 1, 2025). The LillyDirect page we read on Oct 19, 2026 shows $499 and $699 instead. We report the current page and date it.

Lilly’s March 16, 2026 statement is specific: the retail pharmacy card “applies only to the Zepbound KwikPen” and not to single-dose vials or the single-dose pen (Eli Lilly, Mar 16, 2026).

GoodRx coupons for Zepbound

Search results often point to GoodRx coupons for Zepbound. On Oct 19, 2026, the GoodRx Zepbound page (prices “last updated on 10/19/26”) showed a Lilly-sponsored “manufacturer offer” of $299 a month for the 2.5 mg KwikPen, self-pay only, with pharmacies listed at $299.00 (GoodRx, Oct 19, 2026). That is the same $299 KwikPen price Lilly lists. It is not a separate GoodRx-negotiated discount on Zepbound. We did not find a lower GoodRx price to report.

Annual totals at the listed prices

Monthly prices can hide the yearly number. This table multiplies the prices Lilly listed on Oct 19, 2026 by 13 fills. Thirteen is the fill limit on the single-dose pen cards. For LillyDirect it is our arithmetic for one year of 28-day months, not a Lilly figure.

Real-world totals will differ. Under the label, 2.5 mg is used for the first 4 weeks only, and the dose often changes during the year (DailyMed, Aug 28, 2026). The tirzepatide cost calculator can lay out the label ladder week by week and apply a price you enter.

Fine print worth reading before a fill

• Terms can change at any time. Lilly says its program terms may be terminated, rescinded, revoked or amended without notice (Eli Lilly, Sep 1, 2026).
• Eligibility is required. The savings page notes “Eligibility required, terms and conditions apply,” with monthly and annual limits (Eli Lilly, Sep 1, 2026).
• Cards are presentation-specific. The covered-plan card is for the single-dose pen. The KwikPen has its own card. The retail KwikPen card does not apply to vials or the single-dose pen (Eli Lilly, Mar 16, 2026).
• KwikPen card limits. For each KwikPen dose, a month is 28 days and up to 1 KwikPen. The card covers up to 11 fills a calendar year. Post-purchase reimbursement claims must be submitted or postmarked by March 31, 2027 (Eli Lilly, Sep 1, 2026).
• The KwikPen holds 4 doses. The label lists the KwikPen and multi-dose vial as 4-dose presentations, so one KwikPen covers 4 weekly doses (DailyMed, Aug 28, 2026).
• Compounded tirzepatide is a different product. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed (FDA, Oct 1, 2026). Lilly’s programs on this page are for Lilly’s Zepbound presentations, and compounded products are not interchangeable with Zepbound.

Storage rules differ by presentation as well, which matters if you switch from vials to a KwikPen. See the tirzepatide storage tool and the tirzepatide hub for label facts on each form. If you use Mounjaro instead, its card has different caps; see the Mounjaro savings card guide.

Talk to your prescriber or pharmacist about which presentation and dose fit your prescription. This page reports program terms; it does not recommend a route.